Lite Strategy, Inc. — Director's Dealing 2017

Apr 4, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2017-04-03

Reporting Person: Drazba Brian G. (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-04-03	Option to purchase shares of common stock	$1.59	A	150000	Acquired	2027-04-03	Common Stock par value $0.00000002 (150000)	Direct

Footnotes

F1: One-quarter of the options will vest on April 3, 2018; the remaining three-quarters of the options will vest in equal monthly installments over the following thirty-six months.